TLR1 and neoplasm: In contrast, tumor regression was markedly reduced in the OXP/Pam3CSK4 group compared to mice that received OXP only (Fig. 3B–D), suggesting that activation of TLR1/2 signaling may enhance the therapeutic efficacy of OXP.